TFF Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Hi, everyone. Welcome to the 2023 Jefferies Global Healthcare Conference. My name is Shreya Chowdhry. I'm from the Jefferies healthcare investment banking team. It's my pleasure today to introduce to you the CEO of TFF Pharmaceuticals, Dr. Harlan Weisman.
Thank you so much for being here.
Imagine if you had a powerful, highly effective drug limited by severe systemic toxicities, what if you could aim that drug directly to the target tissue, eliminating the systemic effects, thereby dramatically improving the efficacy and safety, and eliminating drug-drug interactions. That, in a nutshell, is what TFF is doing.
We have a proprietary, unique patented drug delivery technology where we're able to convert a wide variety of molecules into inhalable dry powders. We have a strong internal pipeline comprising two products currently in Phase 2 development.
One of them is TFF VORI or inhaled voriconazole dry powder, which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
